Editorial: Cytotoxic drugs and lupus nephritis.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone